Provided by Tiger Trade Technology Pte. Ltd.

Health Care Select Sector SPDR Fund

169.24
+1.080.64%
Volume:1.85M
Turnover:313.39M
Market Cap:43.67B
PE:-11.90
High:170.49
Open:167.66
Low:167.52
Close:168.16
52wk High:176.60
52wk Low:141.05
Shares:258.02M
Float Shares:258.02M
Volume Ratio:0.96
T/O Rate:0.72%
Dividend:2.45
Dividend Rate:1.44%
EPS(TTM):-14.2170
EPS(LYR):-14.2170
ROE:-9.22%
ROA:1.03%
PB:1.27
PE(LYR):-11.90

Loading ...

UnitedHealthcare, Aetna Say 2027 Medicare Advantage Plans to Offer More Limited Provider Networks

Reuters
·
Oct 01

Merck Schedules Third-Quarter Sales and Earnings Conference Call with Investors and Analysts

Reuters
·
Oct 01

Johnson & Johnson (JNJ) Stock Could Be Undervalued On Future Cash Flow

Simply Wall St.
·
Oct 01

Analysts Offer Insights on Healthcare Companies: AbSci (ABSI), Summit Therapeutics (SMMT) and Sutro Biopharma (STRO)

TIPRANKS
·
Oct 01

Health Care Roundup: Market Talk

Dow Jones
·
Oct 01

Sonic Healthcare Details Changes in Director Equity Incentives

TIPRANKS
·
Oct 01

Sunway Healthcare Extends Heads of Agreement for Hospital Project with Putrajaya Holdings

MT Newswires Live
·
Oct 01

Merck & Co Inc : Jefferies Raises Target Price to $177 from $175

THOMSON REUTERS
·
Oct 01

Promisia completes Chatswood Retirement Village deal with share and note issue

TIPRANKS
·
Oct 01

RBC Capital Keeps Their Hold Rating on Merck & Company (MRK)

TIPRANKS
·
Oct 01

The Next Frontier for Obesity Drugs Isn't How Much Weight You Lose, but What Kind

Dow Jones
·
Oct 01

HealthCo Healthcare & Wellness REIT (HCW) Gets a Buy from Macquarie

TIPRANKS
·
Oct 01

Austco Healthcare Issues New Unquoted Performance Rights Under Incentive Scheme

TIPRANKS
·
Oct 01

Eli Lilly Says Foundayo Drug Helped Patients Lose Weight in Phase 3 Trial

Dow Jones
·
Oct 01

Eli Lilly’s Foundayo shows cardiovascular safety in type 2 diabetes study

TIPRANKS
·
Oct 01

Lilly's Oral Glp-1, Foundayo (Orforglipron), Demonstrated Cardiovascular Safety Alongside Sustained A1c Reduction and Weight Loss in Its Largest and Longest Type 2 Diabetes Study

THOMSON REUTERS
·
Oct 01

Eli Lilly - Achieve-4: Foundayo Shows 16% Lower Mace-4 and 23% Lower Mace-3 Risk vs Insulin Glargine

THOMSON REUTERS
·
Oct 01

Eli Lilly - Foundayo Shows Smaller Egrf Reduction and Greater Albuminuria Reduction vs Insulin Glargine

THOMSON REUTERS
·
Oct 01

Grindr to Acquire PurposeMed, Expanding LGBTQ+ Healthcare

TIPRANKS
·
Oct 01

Trump Sending $500 Checks with Letter Touting Healthcare Record

Dow Jones
·
Oct 01